IBDEI09Z ; ; 19-NOV-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13282,1,1,0)
 ;;=1^COMP HX/EXAM,HIGH MDM
 ;;^UTILITY(U,$J,358.3,13282,1,2,0)
 ;;=2^99223
 ;;^UTILITY(U,$J,358.3,13283,0)
 ;;=99231^^68^745^1
 ;;^UTILITY(U,$J,358.3,13283,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13283,1,1,0)
 ;;=1^PF HX/EXAM,SF MDM
 ;;^UTILITY(U,$J,358.3,13283,1,2,0)
 ;;=2^99231
 ;;^UTILITY(U,$J,358.3,13284,0)
 ;;=99232^^68^745^2
 ;;^UTILITY(U,$J,358.3,13284,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13284,1,1,0)
 ;;=1^EPF HX/EXAM,MOD MDM
 ;;^UTILITY(U,$J,358.3,13284,1,2,0)
 ;;=2^99232
 ;;^UTILITY(U,$J,358.3,13285,0)
 ;;=99233^^68^745^3
 ;;^UTILITY(U,$J,358.3,13285,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13285,1,1,0)
 ;;=1^DET HX/EXAM,HIGH MDM
 ;;^UTILITY(U,$J,358.3,13285,1,2,0)
 ;;=2^99233
 ;;^UTILITY(U,$J,358.3,13286,0)
 ;;=99238^^68^746^1
 ;;^UTILITY(U,$J,358.3,13286,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13286,1,1,0)
 ;;=1^D/C Visit incl Pronouncement of Death < 31min
 ;;^UTILITY(U,$J,358.3,13286,1,2,0)
 ;;=2^99238
 ;;^UTILITY(U,$J,358.3,13287,0)
 ;;=99239^^68^746^2
 ;;^UTILITY(U,$J,358.3,13287,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13287,1,1,0)
 ;;=1^D/C Visit incl Pronouncement of Death > 30min
 ;;^UTILITY(U,$J,358.3,13287,1,2,0)
 ;;=2^99239
 ;;^UTILITY(U,$J,358.3,13288,0)
 ;;=188.9^^69^747^5
 ;;^UTILITY(U,$J,358.3,13288,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13288,1,1,0)
 ;;=1^188.9
 ;;^UTILITY(U,$J,358.3,13288,1,2,0)
 ;;=2^BLADDER CANCER
 ;;^UTILITY(U,$J,358.3,13288,2)
 ;;=^267253
 ;;^UTILITY(U,$J,358.3,13289,0)
 ;;=162.9^^69^747^25
 ;;^UTILITY(U,$J,358.3,13289,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13289,1,1,0)
 ;;=1^162.9
 ;;^UTILITY(U,$J,358.3,13289,1,2,0)
 ;;=2^LUNG CANCER
 ;;^UTILITY(U,$J,358.3,13289,2)
 ;;=^73521
 ;;^UTILITY(U,$J,358.3,13290,0)
 ;;=191.9^^69^747^7
 ;;^UTILITY(U,$J,358.3,13290,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13290,1,1,0)
 ;;=1^191.9
 ;;^UTILITY(U,$J,358.3,13290,1,2,0)
 ;;=2^BRAIN CANCER
 ;;^UTILITY(U,$J,358.3,13290,2)
 ;;=^267279
 ;;^UTILITY(U,$J,358.3,13291,0)
 ;;=171.9^^69^747^50
 ;;^UTILITY(U,$J,358.3,13291,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13291,1,1,0)
 ;;=1^171.9
 ;;^UTILITY(U,$J,358.3,13291,1,2,0)
 ;;=2^SARCOMAS/OTH SOFT TISSUE CANCER
 ;;^UTILITY(U,$J,358.3,13291,2)
 ;;=^267165
 ;;^UTILITY(U,$J,358.3,13292,0)
 ;;=150.9^^69^747^16
 ;;^UTILITY(U,$J,358.3,13292,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13292,1,1,0)
 ;;=1^150.9
 ;;^UTILITY(U,$J,358.3,13292,1,2,0)
 ;;=2^ESOPHAGEAL CANCER
 ;;^UTILITY(U,$J,358.3,13292,2)
 ;;=^267055
 ;;^UTILITY(U,$J,358.3,13293,0)
 ;;=153.9^^69^747^15
 ;;^UTILITY(U,$J,358.3,13293,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13293,1,1,0)
 ;;=1^153.9
 ;;^UTILITY(U,$J,358.3,13293,1,2,0)
 ;;=2^COLON CANCER
 ;;^UTILITY(U,$J,358.3,13293,2)
 ;;=^267078
 ;;^UTILITY(U,$J,358.3,13294,0)
 ;;=152.9^^69^747^55
 ;;^UTILITY(U,$J,358.3,13294,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13294,1,1,0)
 ;;=1^152.9
 ;;^UTILITY(U,$J,358.3,13294,1,2,0)
 ;;=2^SMALL INTESTINE CANCER
 ;;^UTILITY(U,$J,358.3,13294,2)
 ;;=^267077
 ;;^UTILITY(U,$J,358.3,13295,0)
 ;;=193.^^69^747^60
 ;;^UTILITY(U,$J,358.3,13295,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13295,1,1,0)
 ;;=1^193.
 ;;^UTILITY(U,$J,358.3,13295,1,2,0)
 ;;=2^THYROID CANCER
 ;;^UTILITY(U,$J,358.3,13295,2)
 ;;=^267296
 ;;^UTILITY(U,$J,358.3,13296,0)
 ;;=284.9^^69^747^3
 ;;^UTILITY(U,$J,358.3,13296,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13296,1,1,0)
 ;;=1^284.9
 ;;^UTILITY(U,$J,358.3,13296,1,2,0)
 ;;=2^APLASTIC ANEMIA NOS
 ;;^UTILITY(U,$J,358.3,13296,2)
 ;;=^7020
 ;;^UTILITY(U,$J,358.3,13297,0)
 ;;=170.9^^69^747^6
 ;;^UTILITY(U,$J,358.3,13297,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13297,1,1,0)
 ;;=1^170.9
 ;;^UTILITY(U,$J,358.3,13297,1,2,0)
 ;;=2^BONE AND CARTILAGE CANCER
 ;;^UTILITY(U,$J,358.3,13297,2)
 ;;=^267155
 ;;^UTILITY(U,$J,358.3,13298,0)
 ;;=175.9^^69^747^9
 ;;^UTILITY(U,$J,358.3,13298,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13298,1,1,0)
 ;;=1^175.9
 ;;^UTILITY(U,$J,358.3,13298,1,2,0)
 ;;=2^BREAST CANCER-MALE
 ;;^UTILITY(U,$J,358.3,13298,2)
 ;;=^267205
 ;;^UTILITY(U,$J,358.3,13299,0)
 ;;=209.10^^69^747^10
 ;;^UTILITY(U,$J,358.3,13299,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13299,1,1,0)
 ;;=1^209.10
 ;;^UTILITY(U,$J,358.3,13299,1,2,0)
 ;;=2^CARCINOID, LARGE INTESTINE
 ;;^UTILITY(U,$J,358.3,13299,2)
 ;;=^336722
 ;;^UTILITY(U,$J,358.3,13300,0)
 ;;=209.29^^69^747^11
 ;;^UTILITY(U,$J,358.3,13300,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13300,1,1,0)
 ;;=1^209.29
 ;;^UTILITY(U,$J,358.3,13300,1,2,0)
 ;;=2^CARCINOID,NONBOWEL AND OTH SITE
 ;;^UTILITY(U,$J,358.3,13300,2)
 ;;=^336507
 ;;^UTILITY(U,$J,358.3,13301,0)
 ;;=209.00^^69^747^12
 ;;^UTILITY(U,$J,358.3,13301,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13301,1,1,0)
 ;;=1^209.00
 ;;^UTILITY(U,$J,358.3,13301,1,2,0)
 ;;=2^CARCINOID,SMALL INTESTINE
 ;;^UTILITY(U,$J,358.3,13301,2)
 ;;=^336721
 ;;^UTILITY(U,$J,358.3,13302,0)
 ;;=156.9^^69^747^13
 ;;^UTILITY(U,$J,358.3,13302,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13302,1,1,0)
 ;;=1^156.9
 ;;^UTILITY(U,$J,358.3,13302,1,2,0)
 ;;=2^CHOLANGIOCARCINOMA
 ;;^UTILITY(U,$J,358.3,13302,2)
 ;;=^267102
 ;;^UTILITY(U,$J,358.3,13303,0)
 ;;=286.9^^69^747^14
 ;;^UTILITY(U,$J,358.3,13303,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13303,1,1,0)
 ;;=1^286.9
 ;;^UTILITY(U,$J,358.3,13303,1,2,0)
 ;;=2^COAGULATION DEFECTS
 ;;^UTILITY(U,$J,358.3,13303,2)
 ;;=^87267
 ;;^UTILITY(U,$J,358.3,13304,0)
 ;;=156.9^^69^747^17
 ;;^UTILITY(U,$J,358.3,13304,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13304,1,1,0)
 ;;=1^156.9
 ;;^UTILITY(U,$J,358.3,13304,1,2,0)
 ;;=2^GALLBLADDER CANCER
 ;;^UTILITY(U,$J,358.3,13304,2)
 ;;=^267102
 ;;^UTILITY(U,$J,358.3,13305,0)
 ;;=459.0^^69^747^19
 ;;^UTILITY(U,$J,358.3,13305,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13305,1,1,0)
 ;;=1^459.0
 ;;^UTILITY(U,$J,358.3,13305,1,2,0)
 ;;=2^HEMORRHAGE NOS
 ;;^UTILITY(U,$J,358.3,13305,2)
 ;;=^55877
 ;;^UTILITY(U,$J,358.3,13306,0)
 ;;=176.9^^69^747^20
 ;;^UTILITY(U,$J,358.3,13306,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13306,1,1,0)
 ;;=1^176.9
 ;;^UTILITY(U,$J,358.3,13306,1,2,0)
 ;;=2^KAPOSI'S SARCOMA, NOS
 ;;^UTILITY(U,$J,358.3,13306,2)
 ;;=^107993
 ;;^UTILITY(U,$J,358.3,13307,0)
 ;;=161.9^^69^747^21
 ;;^UTILITY(U,$J,358.3,13307,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13307,1,1,0)
 ;;=1^161.9
 ;;^UTILITY(U,$J,358.3,13307,1,2,0)
 ;;=2^LARYNGEAL CANCER
 ;;^UTILITY(U,$J,358.3,13307,2)
 ;;=^267128
 ;;^UTILITY(U,$J,358.3,13308,0)
 ;;=208.90^^69^747^22
 ;;^UTILITY(U,$J,358.3,13308,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13308,1,1,0)
 ;;=1^208.90
 ;;^UTILITY(U,$J,358.3,13308,1,2,0)
 ;;=2^LEUKEMIA,UNSP CELL TYPE
 ;;^UTILITY(U,$J,358.3,13308,2)
 ;;=^336874
 ;;^UTILITY(U,$J,358.3,13309,0)
 ;;=140.9^^69^747^23
 ;;^UTILITY(U,$J,358.3,13309,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13309,1,1,0)
 ;;=1^140.9
 ;;^UTILITY(U,$J,358.3,13309,1,2,0)
 ;;=2^LIP CANCER
 ;;^UTILITY(U,$J,358.3,13309,2)
 ;;=^266994
 ;;^UTILITY(U,$J,358.3,13310,0)
 ;;=155.0^^69^747^24
 ;;^UTILITY(U,$J,358.3,13310,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13310,1,1,0)
 ;;=1^155.0
 ;;^UTILITY(U,$J,358.3,13310,1,2,0)
 ;;=2^LIVER CANCER
 ;;^UTILITY(U,$J,358.3,13310,2)
 ;;=^73526
 ;;^UTILITY(U,$J,358.3,13311,0)
 ;;=200.60^^69^747^26
 ;;^UTILITY(U,$J,358.3,13311,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13311,1,1,0)
 ;;=1^200.60
 ;;^UTILITY(U,$J,358.3,13311,1,2,0)
 ;;=2^LYMPHOMA,ANAPLASTIC LARGE CELL
 ;;^UTILITY(U,$J,358.3,13311,2)
 ;;=^335299
 ;;^UTILITY(U,$J,358.3,13312,0)
 ;;=200.20^^69^747^27
 ;;^UTILITY(U,$J,358.3,13312,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13312,1,1,0)
 ;;=1^200.20
 ;;^UTILITY(U,$J,358.3,13312,1,2,0)
 ;;=2^LYMPHOMA,BURKITT'S
 ;;^UTILITY(U,$J,358.3,13312,2)
 ;;=^17529
 ;;^UTILITY(U,$J,358.3,13313,0)
 ;;=201.90^^69^747^28
 ;;^UTILITY(U,$J,358.3,13313,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13313,1,1,0)
 ;;=1^201.90
 ;;^UTILITY(U,$J,358.3,13313,1,2,0)
 ;;=2^LYMPHOMA,HODGKIN'S
 ;;^UTILITY(U,$J,358.3,13313,2)
 ;;=^267430
 ;;^UTILITY(U,$J,358.3,13314,0)
 ;;=200.70^^69^747^29
 ;;^UTILITY(U,$J,358.3,13314,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13314,1,1,0)
 ;;=1^200.70
 ;;^UTILITY(U,$J,358.3,13314,1,2,0)
 ;;=2^LYMPHOMA,LARGE CELL
 ;;^UTILITY(U,$J,358.3,13314,2)
 ;;=^335300
 ;;^UTILITY(U,$J,358.3,13315,0)
 ;;=200.40^^69^747^30
 ;;^UTILITY(U,$J,358.3,13315,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13315,1,1,0)
 ;;=1^200.40
 ;;^UTILITY(U,$J,358.3,13315,1,2,0)
 ;;=2^LYMPHOMA,MANTLE CELL
 ;;^UTILITY(U,$J,358.3,13315,2)
 ;;=^335297
 ;;^UTILITY(U,$J,358.3,13316,0)
 ;;=200.30^^69^747^31
 ;;^UTILITY(U,$J,358.3,13316,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13316,1,1,0)
 ;;=1^200.30
 ;;^UTILITY(U,$J,358.3,13316,1,2,0)
 ;;=2^LYMPHOMA,MARGINAL ZONE
 ;;^UTILITY(U,$J,358.3,13316,2)
 ;;=^335296
 ;;^UTILITY(U,$J,358.3,13317,0)
 ;;=200.50^^69^747^33
 ;;^UTILITY(U,$J,358.3,13317,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13317,1,1,0)
 ;;=1^200.50
 ;;^UTILITY(U,$J,358.3,13317,1,2,0)
 ;;=2^LYMPHOMA,PRIM CTR NERVOUS SYS
 ;;^UTILITY(U,$J,358.3,13317,2)
 ;;=^335298
 ;;^UTILITY(U,$J,358.3,13318,0)
 ;;=202.90^^69^747^32
 ;;^UTILITY(U,$J,358.3,13318,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13318,1,1,0)
 ;;=1^202.90
 ;;^UTILITY(U,$J,358.3,13318,1,2,0)
 ;;=2^LYMPHOMA,OTHER SITE
 ;;^UTILITY(U,$J,358.3,13318,2)
 ;;=^267504
 ;;^UTILITY(U,$J,358.3,13319,0)
 ;;=200.10^^69^747^34
 ;;^UTILITY(U,$J,358.3,13319,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13319,1,1,0)
 ;;=1^200.10
 ;;^UTILITY(U,$J,358.3,13319,1,2,0)
 ;;=2^LYMPHOSARCOMA
 ;;^UTILITY(U,$J,358.3,13319,2)
 ;;=^175886
 ;;^UTILITY(U,$J,358.3,13320,0)
 ;;=172.9^^69^747^35
 ;;^UTILITY(U,$J,358.3,13320,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13320,1,1,0)
 ;;=1^172.9
 ;;^UTILITY(U,$J,358.3,13320,1,2,0)
 ;;=2^MALIGNANT MELANOMA
 ;;^UTILITY(U,$J,358.3,13320,2)
 ;;=^75462
 ;;^UTILITY(U,$J,358.3,13321,0)
 ;;=199.0^^69^747^37
